Comment on "Long-term outcomes of neoadjuvant gefitinib in resectable stage II-IIIA non-small cell lung cancer: A phase II, prospective cohort study". Zhang B, Zhang J. Lung Cancer 2025;204:108515.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang B, Zhang J. Comment on "Long-term outcomes of neoadjuvant gefitinib in resectable stage II-IIIA non-small cell lung cancer: A phase II, prospective cohort study". Lung Cancer 2025;204:108515.
PMID: 40473338